Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, et al. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism. Sartorato P, Khaldi Y, Lapeyraque AL, et al. Aldosterone synthase deficiency and related disorders. Inborn errors of adrenal steroidogenesis. Toad venom poisoning: resemblance to digoxin toxicity and therapeutic implications. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Nowicki TS, Bjornard K, Kudlowitz D, Sandoval C, Jayabose S. Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, et al. Fluoride-induced hyperkalemia: the role of Ca2+-dependent K+ channels. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pavlakovic H, Kietz S, Lauerer P, Zutt M, Lakomek M. Sánchez-Carpintero I, Ruiz-Rodriguez R, López-Gutiérrez JC. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Rossignol P, et al Heart Failure Long-Term Registry Investigators Group. The importance of developing hyperkalaemia in heart failure during long-term follow-up. Martens P, Kooij J, Maessen L, Dauw J, Dupont M, Mullens W. Electrocardiographic manifestations of hyperkalemia. The effects of epsilon amino-caproic acid upon potassium metabolism in the dog. Acute hyperkalemia associated with intravenous epsilon-aminocaproic acid therapy. Pathophysiology of hyperkalemia induced by succinylcholine. Hyperkalemia and cardiac arrest following succinylcholine administration in a 16-year-old boy with acute nonlymphoblastic leukemia and sepsis. The propofol infusion 'syndrome' in intensive care unit: from pathophysiology to prophylaxis and treatment. Papaioannou V, Dragoumanis C, Theodorou V, Pneumatikos I. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1. Schweiger B, Moriarty MW, Cadnapaphornchai MA. The management of hyperkalemia in patients with cardiovascular disease. Mechanisms of impaired potassium handling with dual renin-angiotensin-aldosterone blockade in chronic kidney disease. Potassium homeostasis and Renin-Angiotensin-aldosterone system inhibitors. Renin-angiotensin system blockade is not associated with hyperkalemia in chronic hemodialysis patients. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. Johnson ES, Weinstein JR, Thorp ML, et al. Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring. The frequency of hyperkalemia and its significance in chronic kidney disease. 105(2):344-50.Įinhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, et al.
HYPERKALEMIA ECG FINDINGS UPDATE
Anesthesia-related cardiac arrest in children: update from the Pediatric Perioperative Cardiac Arrest Registry. 373 (1):60-72.īhananker SM, Ramamoorthy C, Geiduschek JM, Posner KL, Domino KB, Haberkern CM, et al. An Integrated View of Potassium Homeostasis. Evidence for a gastrointestinal-renal kaliuretic signaling axis in humans. Preston RA, Afshartous D, Rodco R, Alonso AB, Garg D. Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases. The WNK kinase network regulating sodium, potassium, and blood pressure. Hoorn EJ, Nelson JH, McCormick JA, Ellison DH. Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Hyperkalemia in very low birth weight infants.
Shaffer SG, Kilbride HW, Hayen LK, Meade VM, Warady BA. WNK kinases, renal ion transport and hypertension. San-Cristobal P, de los Heros P, Ponce-Coria J, et al. Electrocardiographic manifestations: electrolyte abnormalities. Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations.
Murata K, Baumann NA, Saenger AK, Larson TS, Rule AD, Lieske JC.
0 kommentar(er)
